Everett Harris & CO Baxter International Inc Transaction History

Everett Harris & CO

$8 Billion
Q3 2024

A detailed history of Everett Harris & CO transactions in Baxter International Inc stock. As of the latest transaction made, Everett Harris & CO holds 550,579 shares of BAX stock, worth $19.7 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

550,579

Previous 563,908 2.36%

Holding current value

$19.7 Million

Previous $18.9 Million 10.83%

% of portfolio

0.26%

Previous 0.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$32.85 - $40.26 $437,857 - $536,625	-13,329 Reduced 2.36%	550,579 $20.9 Million
Q2 2024 Aug 01, 2024	SELL	$32.87 - $43.55 $127,634 - $169,104	-3,883 Reduced 0.68%	563,908 $18.9 Million
Q1 2024 Apr 19, 2024	SELL	$37.88 - $43.77 $166,596 - $192,500	-4,398 Reduced 0.77%	567,791 $24.3 Million
Q4 2023 Jan 18, 2024	SELL	$31.71 - $38.95 $1.07 Million - $1.31 Million	-33,665 Reduced 5.56%	572,189 $22.1 Million
Q3 2023 Oct 23, 2023	SELL	$37.32 - $49.29 $818,763 - $1.08 Million	-21,939 Reduced 3.49%	605,854 $22.9 Million
Q2 2023 Jul 26, 2023	SELL	$39.98 - $47.68 $5.06 Million - $6.04 Million	-126,639 Reduced 16.79%	627,793 $28.6 Million
Q1 2023 Apr 24, 2023	BUY	$37.58 - $52.57 $707,368 - $989,525	18,823 Added 2.56%	754,432 $30.6 Million
Q4 2022 Jan 20, 2023	BUY	$49.7 - $57.71 $394,667 - $458,275	7,941 Added 1.09%	735,609 $0
Q3 2022 Oct 21, 2022	BUY	$53.86 - $66.8 $3.53 Million - $4.37 Million	65,465 Added 9.89%	727,668 $39.2 Million
Q2 2022 Jul 22, 2022	SELL	$63.83 - $80.0 $84,957 - $106,480	-1,331 Reduced 0.2%	662,203 $42.5 Million
Q1 2022 Apr 22, 2022	BUY	$76.85 - $89.45 $601,812 - $700,482	7,831 Added 1.19%	663,534 $51.5 Million
Q4 2021 Feb 02, 2022	BUY	$74.57 - $87.19 $570,758 - $667,352	7,654 Added 1.18%	655,703 $56.3 Million
Q3 2021 Nov 03, 2021	BUY	$73.77 - $83.61 $123,195 - $139,628	1,670 Added 0.26%	648,049 $52.1 Million
Q2 2021 Jul 29, 2021	SELL	$80.5 - $88.01 $101,269 - $110,716	-1,258 Reduced 0.19%	646,379 $52 Million
Q1 2021 May 13, 2021	SELL	$76.38 - $86.03 $308,193 - $347,131	-4,035 Reduced 0.62%	647,637 $54.6 Million
Q4 2020 Feb 04, 2021	BUY	$75.39 - $82.36 $1.28 Million - $1.4 Million	17,016 Added 2.68%	651,672 $52.3 Million
Q3 2020 Nov 03, 2020	BUY	$78.33 - $90.73 $1.52 Million - $1.76 Million	19,419 Added 3.16%	634,656 $51 Million
Q2 2020 Jul 29, 2020	BUY	$78.66 - $94.14 $1.04 Million - $1.24 Million	13,161 Added 2.19%	615,237 $53 Million
Q1 2020 Apr 29, 2020	BUY	$71.57 - $93.3 $5.27 Million - $6.87 Million	73,620 Added 13.93%	602,076 $48.9 Million
Q4 2019 Jan 27, 2020	SELL	$76.7 - $88.45 $45,329 - $52,273	-591 Reduced 0.11%	528,456 $44.2 Million
Q3 2019 Nov 06, 2019	SELL	$81.4 - $89.78 $276,841 - $305,341	-3,401 Reduced 0.64%	529,047 $46.3 Million
Q2 2019 Aug 13, 2019	BUY	$73.44 - $82.41 $8,445 - $9,477	115 Added 0.02%	532,448 $43.6 Million
Q1 2019 May 13, 2019	SELL	$64.48 - $81.31 $1.76 Million - $2.22 Million	-27,284 Reduced 4.88%	532,333 $43.3 Million
Q4 2018 Feb 13, 2019	SELL	$61.45 - $77.8 $270,134 - $342,008	-4,396 Reduced 0.78%	559,617 $36.8 Million
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $43,274 - $47,583	-612 Reduced 0.11%	564,013 $43.5 Million
Q2 2018 Jul 27, 2018	SELL	$63.43 - $75.41 $125,527 - $149,236	-1,979 Reduced 0.35%	564,625 $41.7 Million
Q1 2018 Apr 20, 2018	BUY	$62.56 - $72.26 $4.25 Million - $4.91 Million	67,999 Added 13.64%	566,604 $36.9 Million
Q4 2017 Feb 01, 2018	SELL	$61.45 - $66.05 $43,383 - $46,631	-706 Reduced 0.14%	498,605 $32.2 Million
Q3 2017 Oct 11, 2017	BUY	$59.5 - $64.61 $29.7 Million - $32.3 Million	499,311	499,311 $31.3 Million

Others Institutions Holding BAX

# of Institutions

989

Shares Held

449M

Call Options Held

2.22M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Account

Everett Harris & CO Baxter International Inc Transaction History